Pricing Log in Create free account

Biodesix, Inc. (BDSX) vs Burning Rock Biotech Limited Sponsored ADR (BNR)

Biodesix, Inc. and Burning Rock Biotech Limited Sponsored ADR are both Diagnostics & Research companies. Biodesix, Inc. is the larger, with a market value of $209.3M against $116.5M — 1.8× the size. Biodesix, Inc. grew revenue faster over the last twelve months: 31.2% against −0.14%. Burning Rock Biotech Limited Sponsored ADR has the higher net margin (−13.5% vs −25.7%) and the lower return on invested capital (−50.7% vs −44.8%). Across the 18 metrics below, Burning Rock Biotech Limited Sponsored ADR leads on 12 and Biodesix, Inc. on 6.

Valuation

Metric BDSX BNR Diagnostics & Research median
P/E n/m n/m 34.52
P/S 2.01 19.48 4.24
P/B 24.38 19.57 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m n/m 23.44
EV/Sales 2.19 18.64 5.18
Earnings yield (13.91%) (3.93%) (1.50%)
Free cash flow yield (9.11%) (1.02%) 0.00%

Profitability

Metric BDSX BNR Diagnostics & Research median
Gross margin 0.00% 74.50% 48.32%
Operating margin (18.69%) (12.95%) (5.68%)
Net margin (25.74%) (13.51%) (4.10%)
Free cash flow margin (18.30%) (3.00%) 0.00%
Return on equity (778.89%) (13.08%) 0.00%
Return on assets (29.65%) (8.81%) (6.05%)
Return on invested capital (44.84%) (50.66%) 0.00%

Growth

Metric BDSX BNR Diagnostics & Research median
Revenue growth (TTM) 31.23% (0.14%) 8.99%
EPS growth (last fiscal year) 29.24% 84.16% 20.36%
Revenue growth, 5-year CAGR 14.20% 3.21% 7.30%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BDSX BNR Diagnostics & Research median
Debt to equity 5.43 0.00 0.01
Current ratio 2.96 3.05 2.27
Net debt to EBITDA (1.36) 14.48 0.68

Dividend

Metric BDSX BNR Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric BDSX BNR Diagnostics & Research median
Market cap 209.33m 116.47m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack